EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Evaluation of oxidative stress in dogs and cats with chronic kidney disease

Hilla Chen iD, Gilad Segev iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17230 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Hilla Chen and 1 co-authors. Institution: Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. Major MEDLINE topics: Oxidative Stress, Cat Diseases, Renal Insufficiency, Chronic, Dog Diseases. Cited 8 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Oxidative stress is a potential contributor to chronic kidney disease (CKD) progression but has not been evaluated in dogs and cats with CKD. Hypothesis Oxidative stress is higher in animals with CKD compared with healthy controls and decreases with the advancing CKD stage. The aim of this study was to determine the presence and intensity of oxidative stress in dogs and cats at different CKD stages. Animals Sixty dogs and 30 cats with naturally acquired CKD; 10 dogs and 14 cats, healthy controls.

Methods

Analytical cross-sectional study. Oxidative stress was evaluated by measuring the urinary concentration of F2-isoprostane (uF2-IsoPs) normalized to urinary creatinine.

Results

Urinary F2-isoprostanes normalized to urinary creatinine of healthy dogs and of dogs with CKD Stages 1 to 4 was 3.3 ng/mg, 4.7 ng/mg (range, 1.0-73.4), 2.4 ng/mg (range, 0.4-7.8), 0.52 ng/mg (range, 0.01-2.9), and 0.37 ng/mg (range, 0.01-0.6), respectively. Urinary F2-isoprostanes differed among CKD stages (P < .001), but not compared with controls. uF2-IsoPs of healthy cats and cats with CKD Stages 1 to 4 was 0.68 ng/mg (range, 0.2-1.4), 0.97 ng/mg (range, 0.4-1.8), 0.6 ng/mg (range, 0.002-2.0), 0.94 ng/mg (range, 0.3-2.3), and 0.2 ng/mg (range, 0.01-0.4). Urinary F2-isoprostanes differed among stages (P = .05) but not compared with healthy controls. Conclusion and Clinical Importance Oxidative stress might be present in dogs and cats with CKD. Its magnitude declines as the disease progresses, therefore, it should be considered a potential therapeutic target mostly at the early stages of the disease.

Subjects

MeSH terms (MEDLINE)

Oxidative StressCat DiseasesRenal Insufficiency, ChronicDog DiseasesF2-IsoprostanesAnimalsDogsCatsFemaleCross-Sectional StudiesMaleCreatinineCase-Control Studies

Author keywords

CKD progressionF2‐isprostanesbiomarkersproteinuriarenal diet

Substances

F2-IsoprostanesCreatinine

Authors and institutions

  • Department of Small Animal Internal Medicine, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel.

ORCID profiles: Hilla Chen, Gilad Segev

Cite

APA

Chen, H., & Segev, G. (2024). Evaluation of oxidative stress in dogs and cats with chronic kidney disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17230

Vancouver

Chen H, Segev G. Evaluation of oxidative stress in dogs and cats with chronic kidney disease. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17230

BibTeX
@article{Chen2024,
  author = {Chen, Hilla and Segev, Gilad},
  title = {Evaluation of oxidative stress in dogs and cats with chronic kidney disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17230}
}
Start for free →